Literature DB >> 15222028

Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Zai-Bo Jiang1, Hong Shan, Xin-Ying Shen, Ming-Sheng Huang, Zheng-Ran Li, Kang-Shun Zhu, Shou-Hai Guan.   

Abstract

AIM: To evaluate the palliative therapeutic effects of transjugular intrahepatic portosystemic shunt (TIPS) in portal vein tumor thrombosis (PVTT) complicated by portal hypertension.
METHODS: We performed TIPS for 14 patients with PVTT due to hepatocellular carcinoma (HCC). Of the 14 patients, 8 patients had complete occlusion of the main portal vein, 6 patients had incomplete thrombosis, and 5 patients had portal vein cavernous transformation. Clinical characteristics and average survival time of 14 patients were analysed. Portal vein pressure, ascites, diarrhoea, and variceal bleeding and circumference of abdomen were assessed before and after TIPS.
RESULTS: TIPS was successful in 10 cases, and the successful rate was about 71%. The mean portal vein pressure was reduced from 37.2 mmHg to 18.2 mmHg. After TIPS, the ascites decreased, hemorrhage stopped and the clinical symptoms disappeared in the 10 cases. The average survival time was 132.3 d. The procedure failed in 4 cases because of cavernous transformation in portal vein and severe cirrhosis.
CONCLUSION: TIPS is an effective palliative treatment to control hemorrhage and ascites due to HCC complicated by PVTT.

Entities:  

Mesh:

Year:  2004        PMID: 15222028      PMCID: PMC4572222          DOI: 10.3748/wjg.v10.i13.1881

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

Authors:  G V Papatheodoridis; J Goulis; G Leandro; D Patch; A K Burroughs
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

2.  Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.

Authors:  N Hidajat; T Vogl; H Stobbe; J Schmidt; C Wex; R Lenzen; T Berg; P Neuhaus; R Felix
Journal:  Acta Radiol       Date:  2000-09       Impact factor: 1.990

3.  Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein.

Authors:  T Yamagami; T Nakamura; O Tanaka; W Akada; T Takayama; T Maeda
Journal:  J Vasc Interv Radiol       Date:  1999-05       Impact factor: 3.464

4.  Portal venous thrombosis: percutaneous therapy and outcome.

Authors:  E M Walser; S W NcNees; O DeLa Pena; W N Crow; R A Morgan; R Soloway; T Broughan
Journal:  J Vasc Interv Radiol       Date:  1998 Jan-Feb       Impact factor: 3.464

Review 5.  The use and misuse of transjugular intrahepatic portasystemic shunts.

Authors:  A J Sanyal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

6.  Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report.

Authors:  N Benador; P Grimm; J Lavine; P Rosenthal; V Reznik; J Lemire
Journal:  Pediatr Transplant       Date:  2001-06

7.  The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients.

Authors:  J A Burger; A Ochs; K Wirth; D P Berger; R Mertelsmann; R Engelhardt; M Roessle; K Haag
Journal:  Ann Oncol       Date:  1997-02       Impact factor: 32.976

Review 8.  Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.

Authors:  D Azoulay; D Castaing; A Lemoine; D Samuel; P Majno; M Reynes; B Charpentier; H Bismuth
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

9.  Transjugular intrahepatic portosystemic shunt migration in patients undergoing liver transplantation.

Authors:  Taqi T Khan; Kunam S Reddy; Thomas D Johnston; Fang K Lo; Steven Shedlofsky; Sandra Grubb; Dinesh Ranjan
Journal:  Int Surg       Date:  2002 Oct-Dec

10.  Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding.

Authors:  S W Han; Y E Joo; H S Kim; S K Choi; J S Rew; J K Kim; S J Kim
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

View more
  15 in total

1.  Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.

Authors:  Michael J Wallace; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

2.  Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion.

Authors:  Suraj Mammen; Shyamkumar N Keshava; Sajith Kattiparambil
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

3.  Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistance.

Authors:  Elmar Siewert; Jan Salzmann; Edmund Purucker; Karl Schürmann; Siegfried Matern
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

4.  Effect of Perioperative Comprehensive Nursing Intervention on Transcatheter Arterial Chemoembolization in Patients with Primary Hepatic Carcinoma.

Authors:  Min Hu; Ziyan Fan; Yu Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

5.  Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jian-Bo Zhao; Chao Feng; Qiao-Hua Zhu; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.

Authors:  Junyang Luo; Mingan Li; Youyong Zhang; Haofan Wang; Mingsheng Huang; Zhengran Li; Junwei Chen; Chun Wu; Jiesheng Qian; Shouhai Guan; Zaibo Jiang
Journal:  Eur Radiol       Date:  2018-03-29       Impact factor: 5.315

7.  Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.

Authors:  Bin Qiu; Meng-Fei Zhao; Zhen-Dong Yue; Hong-Wei Zhao; Lei Wang; Zhen-Hua Fan; Fu-Liang He; Shan Dai; Jian-Nan Yao; Fu-Quan Liu
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

8.  Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis.

Authors:  Jian-Bin Zhang; Jie Chen; Jin Zhou; Xu-Ming Wang; Shu Chen; Jian-Guo Chu; Peng Liu; Zhi-Dong Ye
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

9.  TIPS Placement via Combined Transjugular and Transhepatic Approach for Cavernous Portal Vein Occlusion: Targeted Approach.

Authors:  Natanel Jourabchi; Justin Pryce McWilliams; Edward Wolfgang Lee; Steven Sauk; Stephen Thomas Kee
Journal:  Case Rep Radiol       Date:  2013-01-21

10.  The collateral caval shunt as an alternative to classical shunt procedures in patients with recurrent duodenal varices and extrahepatic portal vein thrombosis.

Authors:  Hans Michael Hau; Peter Fellmer; Markus B Schoenberg; Moritz Schmelzle; Mehmet Haluk Morgul; Felix Krenzien; Georg Wiltberger; Albrecht Hoffmeister; Sven Jonas
Journal:  Eur J Med Res       Date:  2014-06-25       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.